arrow
M

Massimo Filippi

vita-salute san raffaele university
H指数:153
被引数:12.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Validation of generative artificial intelligence techniques for synthetic data generation in multiple sclerosis research: A comparison with real-world evidence from the Italian multiple sclerosis registry

生成式人工智能技术在多发性硬化症研究中合成数据生成中的验证:与意大利多发性硬化症登记处真实世界证据的比较

2026-10-140
PRE
Residualized occipital amyloid burden and plasma biomarker profiles in relation to ARIA‐E during anti‐amyloid treatment

残余枕叶淀粉样蛋白负荷与抗淀粉样蛋白治疗期间ARIA‐E相关的血浆生物标志物谱

2026-10-090
OAAI
The SOMIRBD study one year later: feasibility, acceptability, and preliminary findings of a web-based screening model for isolated REM sleep behavior disorder

SOMIRBD研究一年后的成果:一种针对孤立性REM睡眠行为障碍的基于网络的筛查模型的可行性、可接受性及初步发现

2026-10-030
PRE
Migraine in Real-World Clinical Practice: Patient Burden, Healthcare Utilization and Unmet Needs—A Cross-Sectional Analysis of the I-GRAINE Study

偏头痛在真实世界临床实践中的患者负担、医疗资源利用及未满足需求——I-GRAINE研究的横断面分析

2026-09-290
OA
Use of MRI in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease — MAGNIMS consensus recommendations

MRI在视神经脊髓炎谱系障碍和髓鞘少突胶质细胞糖蛋白抗体相关疾病中的应用——MAGNIMS共识建议

2026-09-280
PRE
Ocrelizumab versus ofatumumab efficacy and safety after natalizumab discontinuation in multiple sclerosis: a retrospective real-world comparison

奥瑞利珠单抗与奥法木单抗在多发性硬化患者纳武利珠单抗停药后的疗效与安全性比较:一项回顾性真实世界研究

2026-09-080
PRE
Multimodal assessment of clinical and neural changes following multidisciplinary management in functional motor disorders

功能性运动障碍多学科管理后临床和神经变化的多模态评估

2026-08-060
OAAI
The economic burden of dementia in Europe: COIN-Eu dementia

欧洲痴呆症的经济负担:COIN-Eu痴呆症

2026-07-140
PRE
Challenges and future directions for multiple sclerosis after the 2024 McDonald diagnostic criteria

2024年麦唐纳诊断标准后多发性硬化的挑战与未来方向

2026-07-090
PRE